18 mar 2000 ano - Whelan
Descrição:
Can PMRT improve survival even further if the risk of dying from micrometastatic disease is minimized through the use of systemic therapy?
* reduced LRF by 75%
* improved OS by 17%
Metaanalysis of 18 PMRT trials
Adicionado na linha do tempo:
Data: